Drug development tools in this category use advanced analytics and modelling to support target identification, lead optimisation, preclinical assessment, and clinical trial design across the pharmaceutical R&D lifecycle. These AI solutions in healthcare typically work on multi‑omics, preclinical, clinical, and real‑world data to prioritise assets, refine study plans, and de‑risk portfolios. Key evaluation angles include scientific robustness and reproducibility, data and IP governance, integration with existing discovery and development workflows, and readiness for regulatory engagement.

Browse the AI tools below to identify the Drug Development solutions that best match your data, workflow, and governance requirements.

This category page is for informational purposes only and does not constitute regulatory, clinical, or investment advice; organisations should conduct their own technical, legal, and governance due diligence before selecting any AI solutions in healthcare.